177 results
Page 6 of 9
6-K
EX-99.1
xo8obse
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-99.1
2ttyk0
12 Nov 20
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
8:01am
6-K
EX-99.1
he1o8gpn1plk gdpqpe
3 Nov 20
Current report (foreign)
9:14am
6-K
EX-99.2
ejyxc5oz7jhz
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
zs4 o027ocxe2
27 Oct 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
aqly9d9
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
6-K
EX-10.1
ebgtf
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
t1iwa
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
xaqgziwn8w04syuj49
13 Oct 20
Report of Foreign Private Issuer
9:30am
6-K/A
EX-99.2
3sorueg47momk z6f0zg
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
yfs7 iub8a4cyq
1 Oct 20
Enlivex Reports Positive Allocetra Trial Results in COVID-19 Patients in Severe/Critical Condition
6:06am
6-K
EX-99.1
x1eub
16 Sep 20
Enlivex Announces Allowance of New Chinese Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
ju6z0err 0cut5
25 Aug 20
Enlivex Announces Allowance of New U.S. Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.2
5cm3lq8h09e6l
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
ey5 xwatjz4
10 Aug 20
Enlivex Announces Dosing of First Patient in Clinical Trial of Allocetra in COVID-19 Patients with Severe Illness Respiratory Failure
8:02am
6-K
EX-99.1
lrmdfzyev
18 Jun 20
Enlivex Announces Allowance of New Japanese Patent Application Covering ALLOCETRA Immunotherapy
8:32am
6-K
EX-99.1
nkhy7uiimkixaqrqkyvo
28 May 20
Report of Foreign Private Issuer
9:25am
6-K
EX-99.1
iksb7mct4 h0r
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.2
puubitl
18 May 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
u5avcq3
7 May 20
Enlivex Announces Initiation of Multi-Center Phase II Investigator-Initiated Clinical Trial of Allocetra in COVID-19 Patients
8:01am